Strategic Equity Capital (SEC) Share Price, News & Analysis

Company Overview

Strategic Equity Capital is a specialist alternative equity Trust. Actively managed, it maintains a highly-concentrated portfolio of 15-25 high-quality, dynamic UK smaller companies, each operating in a niche market offering structural growth opportunities. SEC aims to achieve investment growth over a medium-term period, principally through capital growth. The team looks to find companies with the potential to double shareholder value every five years. SEC listed on the London Stock Exchange on 19 July 2005, having raised funds from a range of investors including institutions, pension funds and private banks. The Board consists of five Non-Executive Directors, all independent of the Investment Manager.

Key Stats

• Today's Range: 306 to 309
• 50-Day Range: 306 to 333
• 52-Week Range: 305 to 379
• Volume: 35,590 shs
• Average Volume: 63,071 shs
• Market Capitalization: £141.22 million
• P/E Ratio: 5.52
• Dividend Yield: 0.98%
• Price Target: N/A
• Consensus Rating: N/A

SEC Stock Analysis - Frequently Asked Questions

How have SEC shares performed this year?

Strategic Equity Capital's stock was trading at GBX 331 at the start of the year. Since then, SEC stock has decreased by 7.6% and is now trading at GBX 306.
View the best growth stocks for 2025 here.

How do I buy shares of Strategic Equity Capital?

Shares of SEC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Strategic Equity Capital own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Strategic Equity Capital investors own include Wheaton Precious Metals (WPM), Watchstone Group (WTG), VPC Specialty Lending Investments (VSL), International Biotechnology (IBT), BlackRock World Mining Trust (BRWM), The Biotech Growth Trust (BIOG) and abrdn Asia Focus (AAS).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Financial Services
• Industry: Asset Management
• Sub-Industry: N/A
• Current Symbol: LON:SEC
• CUSIP: N/A
• CIK: N/A
• Web: www.strategicequitycapital.com
• Phone: +44-1392-477500
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX 55.46
• Trailing P/E Ratio: 5.52
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: £25.65 million
• Net Margins: 88.65%
• Pretax Margin: N/A
• Return on Equity: 14.97%
• Return on Assets: 10.64%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 36.83
• Quick Ratio: 7.96

Sales & Book Value

• Annual Sales: £28.94 million
• Price / Sales: 4.88
• Cash Flow: GBX 35.18 per share
• Price / Cash Flow: 8.70
• Book Value: GBX 393.57 per share
• Price / Book: 0.78

Miscellaneous

• Outstanding Shares: 46,150,992
• Free Float: N/A
• Market Cap: £141.22 million
• Optionable: Not Optionable
• Beta: 0.73